Fusariosis in Solid-Organ Transplant Recipients

This study has been completed.
Sponsor:
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00518778
First received: August 17, 2007
Last updated: December 2, 2009
Last verified: December 2009
  Purpose

This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.


Condition
Solid Organ Transplant
Fusariosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Fusariosis in Solid-Organ Transplant Recipients

Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 50
Study Start Date: August 2007
Study Completion Date: December 2009
Detailed Description:

This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.This will help determine prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Solid organ transplant patients diagnosed with fusariosis

Criteria

Inclusion Criteria:

  • Solid-organ transplants (liver, kidney, lung, heart, pancreas, small bowel transplant) diagnosed with fusariosis or infections due to Fusarium, species in our institution

Exclusion Criteria:

  • Those subjects that do not meet inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00518778

Locations
United States, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Adarsh Bhimraj, MD University of Pittsburgh
  More Information

No publications provided

Responsible Party: Adarsh Bhimrah, UPMC
ClinicalTrials.gov Identifier: NCT00518778     History of Changes
Other Study ID Numbers: PRO07070159, investigator funding
Study First Received: August 17, 2007
Last Updated: December 2, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
fusariosis
solid organ transplants

Additional relevant MeSH terms:
Fusariosis
Hyalohyphomycosis
Dermatomycoses
Skin Diseases, Infectious
Infection
Mycoses
Skin Diseases

ClinicalTrials.gov processed this record on August 27, 2014